RLBAX | TBARX | RLBAX / TBARX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 23 years | 3 years | - |
Gain YTD | 2.764 | 3.547 | 78% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 250 | 50000 | 1% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 242B | 967M | 25,026% |
Annual Yield % from dividends | 1.59 | 1.63 | 97% |
Returns for 1 year | 8.36 | 13.57 | 62% |
Returns for 3 years | 15.63 | 23.26 | 67% |
Returns for 5 years | 26.04 | N/A | - |
Returns for 10 years | 46.53 | N/A | - |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
LTPZ | 54.08 | 0.45 | +0.84% |
PIMCO 15+ Year US TIPS ETF | |||
BIB | 56.86 | -0.24 | -0.42% |
ProShares Ultra Nasdaq Biotechnology | |||
FUNL | 43.19 | -0.67 | -1.53% |
CornerCap Fundametrics® Lrg-Cap ETF FUNL | |||
IXN | 86.12 | -2.07 | -2.35% |
iShares Global Tech ETF | |||
BUYZ | 38.55 | -0.94 | -2.37% |
Franklin Disruptive Commerce ETF |